B-vitamins delay Alzheimers disease…
this is the latest study to hit the headlines. The work was performed at the University of Oxford where the lead resarcher, Prof Smith, commented that “This is a very striking, dramatic result. It’s much more than we could have predicted.
Support for this work is reflected with comments such as those from Paul Matthews, Professor of Clinical Neurology, Imperial College, London who said: “This well-conducted study adds substantial new data to previous information suggesting that dietary B vitamins could have beneficial effects on neurodegeneration with ageing.“
The study demonstrated that, on average, taking B vitamins slowed the rate of brain atrophy by 30%, and in many cases reductions was as high as 53% were seen. Prof Smith proposes that the treatment with B vitamins lowers homocysteine. Lower homocysteine reduces brain shrinkage and that is associated with a reduced cognitive decline.
The does of B vitamins in the study were;
- Viramin B6 20mg
- Vitamin B9 (folate) 800mcg (0.8mg)
- Vitamin B12 500mcg (0.5mg)
In some papers, folate was described as vitamin B9. This notation is not commonly displayed on vitamin labels but vitamin B9 = folate!